Spartan Stores (SPTN) Misses Q4 Earnings and Revenue Estimates

Spartan Stores (SPTN) came out with quarterly earnings of $0.35 per share, missing the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.28 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of -7.89%. A quarter ago, it was expected that this grocery store operator and grocery distributor would post earnings of $0.60 per share when it actually produced earnings of $0.54, delivering a surprise of -10%.

Over the last four quarters, the company has surpassed consensus EPS estimates two times.

Spartan Stores, which belongs to the Zacks Food - Natural Foods Products industry, posted revenues of $2.25 billion for the quarter ended December 2023, missing the Zacks Consensus Estimate by 0.99%. This compares to year-ago revenues of $2.31 billion. The company has not been able to beat consensus revenue estimates over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Spartan Stores shares have lost about 2.8% since the beginning of the year versus the S&P 500's gain of 4.8%.

What's Next for Spartan Stores?

While Spartan Stores has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Spartan Stores: mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.63 on $2.91 billion in revenues for the coming quarter and $2.37 on $9.82 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Food - Natural Foods Products is currently in the top 28% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the same industry, Sovos Brands, Inc. (SOVO), is yet to report results for the quarter ended December 2023.

This company is expected to post quarterly earnings of $0.20 per share in its upcoming report, which represents a year-over-year change of +5.3%. The consensus EPS estimate for the quarter has been revised 3.8% higher over the last 30 days to the current level.

Sovos Brands, Inc.'s revenues are expected to be $271.1 million, up 3.4% from the year-ago quarter.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s credited with a “watershed medical breakthrough” and is developing a bustling pipeline of other projects that could make a world of difference for patients suffering from diseases involving the liver, lungs, and blood. This is a timely investment that you can catch while it emerges from its bear market lows.

It could rival or surpass other recent Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

SpartanNash Company (SPTN) : Free Stock Analysis Report

Sovos Brands, Inc. (SOVO) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.